Company Alzex Neuropharma Inc.

Equities

TRRI

US89656L1035

Investment Holding Companies

Market Closed - OTC Markets 12:16:59 2024-07-10 pm EDT 5-day change 1st Jan Change
0.101 USD -49.20% Intraday chart for Alzex Neuropharma Inc. -49.20% -49.50%

Business Summary

Alzex Neuropharma Inc., formerly Trinity Resources Inc., is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.

Number of employees: 11

Managers

Managers TitleAgeSince
Chief Executive Officer 59 12-10-09
Director of Finance/CFO 61 22-01-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 59 12-10-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,505,268 1,490,215 ( 99.00 %) 0 99.00 %

Company contact information

Trinity Resources, Inc.

8275 South Eastern Avenue Suite 200-168

89123, Las Vegas

+310-435-0435

http://trinresinc.com
address Alzex Neuropharma Inc.(TRRI)
  1. Stock Market
  2. Equities
  3. TRRI Stock
  4. Company Alzex Neuropharma Inc.